BIRC5 and acute lymphoblastic leukemia: Moreover, there are a growing number of studies concerning the association between survivin and ALL; Esh et al(12) reported that overexpression of survivin is a candidate parameter for determining poor prognosis in ALL patients, while knockdown of survivin improved the chemotherapeutic response in ALL models (13).